Mometasone (as furoate monohydrate) 50mcg/spray. Mometasone is a corticosteroid ... symptoms in patients ≥2yrs of age. Prophylaxis of nasal symptoms of seasonal allergic rhinitis symptoms ...

to manufacture and market Mometasone Furoate Monohydrate nasal spray, 50 mcg. The spray, which is bioequivalent and therapeutically equivalent to the reference listed drug Nasonex nasal spray ...

Mometasone (as furoate monohydrate) 50mcg/spray; contains benzalkonium chloride. Not for treating asthma. Avoid use in patients with recent nasal ulcers, surgery, or injury that has not healed.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

for its Abbreviated New Drug Application (ANDA) for ipratropium bromide nasal solution (nasal spray), 0.06%, to market a generic equivalent of Atrovent nasal spray, 0.06%, of Boehringer Ingelheim ...

Each unit of the nasal spray contains 665mcg of olopatadine hydrochloride, a histamine-1(H1)-receptor inhibitor, and 25mcg of mometasone furoate ... that the novel spray drug is accessible ...